Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice

Journal of Nutritional Biochemistry

Volumn 25, Issue 4, 2014, Pages 439-445

  Gu, Yeyi ^a   Yu, Shan ^a   Park, Jong Yung ^a   Harvatine, Kevin ^a   Lambert, Joshua D ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Adipose tissue; Cocoa; Inflammation; Obesity; Polyphenol; Theobroma cacao

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; GLUCAGON LIKE PEPTIDE 2; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; NUCLEAR PROTEIN; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA; ENZYME; GLUCAGON-LIKE PEPTIDE-2 (3-33); PEPTIDE FRAGMENT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACAO; CONTROLLED STUDY; ENDOTOXEMIA; GENE EXPRESSION; ICOSANOID METABOLISM; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; ADIPOCYTE; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; CELL SIZE; CHEMICALLY INDUCED; DIET THERAPY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANNICULITIS;

MUS; THEOBROMA CACAO;

ADIPOCYTES; ANIMALS; ARACHIDONIC ACID; CACAO; CELL SIZE; DIET, HIGH-FAT; EICOSANOIDS; ENDOTOXEMIA; ENZYMES; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 2; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; PANNICULITIS; PEPTIDE FRAGMENTS; PHOSPHOLIPASES A2;

EID: 84895921144     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.12.004     Document Type: Article

References (52)

1. Chuang C.-C., McIntosh M.K. Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases. Annu Rev Nutr 2011, 31:155-176.
2. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112:1785-1788.
3. González-Castejón M., Rodriguez-Casado A. Dietary phytochemicals and their potential effects on obesity: a review. Pharmacol Res 2011, 64:438-455.
4. González-Périz A., Clària J. Resolution of adipose tissue inflammation. Sci World J 2010, 10:832-856.
5. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
6. Weisberg S.P., Mccann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
7. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
8. Sears B, Ricordi C. Anti-inflammatory nutrition as a pharmacological approach to treat obesity. J Obes 2011;2011:doi: 10.1155/2011/431985.
9. Iyer A., Fairlie D.P., Prins J.B., Hammock B.D., Brown L. Inflammatory lipid mediators in adipocyte function and obesity. Nat Rev Endocrinol 2010, 6:71-82.
10. Ghoshal S., Trivedi D.B., Graf G.a., Loftin C.D. Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. J Biol Chem 2011, 286:889-898.
11. Mothe-Satney I., Filloux C., Amghar H., Pons C., Bourlier V., Galitzky J., et al. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes 2012, 61:2311-2319.
12. Sears D.D., Miles P.D., Chapman J., Ofrecio J.M., Almazan F., Thapar D., et al. 12/15-Lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice. PLoS One 2009, 4:e7250.
13. Pendyala S., Walker J.M., Holt P.R. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012, 142:1100e2-1101e2.
14. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
15. Chang S., Li L. Metabolic endotoxemia: a novel concept in chronic disease pathology. J Med Sci 2011, 31:191-209.
16. Moreira A.P.B., Texeira T.F.S., Ferreira A.B., Peluzio M.D.C.G., Alfenas R.D.C.G. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012, 108:801-809.
17. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009, 15:1546-1558.
18. Hammerstone J.F., Lazarus S.a., Mitchell a.E., Rucker R., Schmitz H.H. Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem 1999, 47:490-496.
19. Katz D.L., Doughty K., Alli A. Cocoa and chococlate in human health and disease. Antioxid Redox Signal 2011, 15:2779-2811.
20. Corti R., Flammer A.J., Hollenberg N.K., Lüscher T.F. Cocoa and cardiovascular health. Circulation 2009, 119:1433-1441.
21. Monahan K.D. Effect of cocoa/chocolate ingestion on brachial artery flow-mediated dilation and its relevance to cardiovascular health and disease in humans. Arch Biochem Biophys 2012, 527:90-94.
22. Tokede O.A., Gaziano J.M., Djoussé L. Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr 2011, 65:879-886.
23. Engler M.B., Engler M.M. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 2006, 64:109-118.
24. Gu Y., Lambert J.D. Modulation of metabolic syndrome-related inflammation by cocoa. Mol Nutri Food Res 2013, 1-14.
25. Selmi C., Mao T.K., Keen C.L., Schmitz H.H., Gershwin M.E. The anti-inflammatory properties of cocoa flavanols. J Cardiovasc Pharmacol 2006, 47:163-171.
26. Gu Y, Yu S, Lambert JD. Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice. Eur J Nutr 2013:doi 10.1007/s00394-013-0510-1.
27. Gu Y., Hurst W.J., Stuart D. a, Lambert JD. Inhibition of key digestive enzymes by cocoa extracts and procyanidins. J Agric Food Chem 2011, 59:5305-5311.
28. Mlinar B., Marc J., Janez A., M.P. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 2007, 375:20-35.
29. Garcés R., Mancha M. One-step lipid extraction and fatty acid methyl esters preparation from fresh plant tissues. Anal Biochem 1993, 211:139-143.
30. Siriwardhana N., Kalupahana N.S., Cekanova M., Lemieux M., Greer B., Moustaid-Moussa N. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem 2013, 24:613-623.
31. González-Gallego J., García-Mediavilla M.V., Sánchez-Campos S., Tuñón M.J. Fruit polyphenols, immunity and inflammation. Br J Nutr 2010, 104S:15-27.
32. Cherniack E.P. Polyphenols: planting the seeds of treatment for the metabolic syndrome. Nutrition 2011, 27:617-623.
33. Min S.Y., Yang H., Seo S.G., Shin S.H., Chung M.-Y., Kim J., et al. Cocoa polyphenols suppress adipogenesis in vitro and obesity in vivo by targeting insulin receptor. Int J Obes 2013, 37:584-592.
34. Tomaru M., Takano H., Osakabe N., Yasuda A., Inoue K., Yanagisawa R., et al. Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice. Nutrition 2007, 23:351-355.
35. Arner E., Westermark P.O., Spalding K.L., Britton T., Ryde M., Frise J., et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010, 59:105-109.
36. Skurk T., Alberti-Huber C., Herder C., Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007, 92:1023-1033.
37. Imig J.D. Eicosanoids and renal damage in cardiometablic syndrome. Expert Opin Drug Metab Toxicol 2008, 4:165-174.
38. Williams E.S., Baylin A., Campos H. Adipose tissue arachidonic acid and the metabolic syndrome in Costa Rican adults. Clin Nutr 2007, 26:474-482.
39. Jaworski K., Ahmadian M., Duncan R.E., Sarkadi-Nagy E., Varady K.a., Hellerstein M.K., et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med 2009, 15:159-168.
40. Wolf G. Adipose-specific phospholipase as regulator of adiposity. Nutr Rev 2009, 67:551-554.
41. Horrillo R., González-Périz A., Martínez-Clemente M., López-Parra M., Ferré N., Titos E., et al. 5-Lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J Immunol 2010, 184:3978-3987.
42. Zhang W.-Y., Liu H.-Q., Xie K.-Q., Yin L.-L., Li Y., Kwik-Uribe C.L., et al. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] suppresses the expression of cyclooxygenase-2 in endotoxin-treated monocytic cells. Biochem Biophys Res Commun 2006, 345:508-515.
43. Calixto J., Otuki M., Santos A. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB). Planta Med 2003, 69:973-983.
44. Terra X., Pallarés V., Ardèvol A., Bladé C., Fernández-Larrea J., Pujadas G., et al. Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats. J Nutr Biochem 2011, 22:380-387.
45. Zeng H., Locatelli M., Bardelli C., Amoruso A., Coisson J.D., Travaglia F., et al. Anti-inflammatory properties of clovamide and Theobroma cacao phenolic extracts in human monocytes: evaluation of respiratory burst, cytokine release, NF-KB activation, and PPARγ modulation. J Agric Food Chem 2011, 59:5342-5350.
46. Mackenzie G.G., Carrasquedo F., Delfino J.M., Keen C.L., Fraga C.G., Oteiza P.I. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J 2004, 18:167-169.
47. Recio M.C., Giner R.M., Cienfuegos-jovellanos E., Laghi S., Ríos L. Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells. J Agric Food Chem 2011, 59:6474-6483.
48. Vazquez-prieto M.A., Bettaieb A., Haj F.G., Fraga C.G., Oteiza P.I. (-)-Epicatechin prevents TNFa-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch Biochem Biophys 2012, 527:113-118.
49. Déprez S., Brezillon C., Rabot S., Philippe C., Mila I., Lapierre C., et al. Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J Nutr 2000, 130:2733-2738.
50. Massot-Cladera M., Pérez-Berezo T., Franch A., Castell M., Pérez-Cano F.J. Cocoa modulatory effect on rat faecal microbiota and colonic crosstalk. Arch Biochem Biophys 2012, 527:105-112.
51. Marathe C.S., Rayner C.K., Jones K.L., Horowitz M. Glucagon-like peptides 1 and 2 in health and disease: a review. Peptides 2013, 44:75-86.
52. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard a., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.